We are pleased to announce that the early bird rates...Read More
The Organising Committee is working hard to deliver a face-to-face Congress. In the unfortunate event that this is not possible, APLAR 2022 will be converted to a hybrid event and those who cannot join us physically in Hong Kong, will receive a full refund of the price difference between physical and virtual registration.
Stay up to date with the latest news for APLAR 2022. Alternatively, join our mailing list and receive news updates directly into your inbox.
Each year, APLAR receives hundreds of abstract submissions, and each year we collect the most stand out and relevant ones to the field.
250 + expert presentations and specially curated industry symposia session available.
Access to industry symposia sessions featuring the most important advances in Asia Pacific for clinical rheumatology treatment.
APLAR prides itself on offer reasonable registration fees amongst rheumatology meetings. See more details on our registration page.
Four action-packed days, all with exclusive keynote speakers, and industry events.
Hong Kong welcomes with an iconic skyline, a legendary kitchen, and lush, protected nature where rare birds and colourful traditions thrive. Hong Kong’s enchanting neighbourhoods and islands offer a sensory feast.
View our video for the upcoming events and action-packed days that are filled with plenary speakers and industry sponsored presentations.
Dr Ronald ML Yip
APLAR 2022 Hong Kong Congress
Professor Debashish Danda
Join us at the #APLAR22 Welcome Reception, for some light refreshments, drinks, ...Read More
Highlights of the #APLAR22 Program: 'Osteoporosis special interest group session...Read More
#APLAR22 Invited Speaker: Prof. Briggs' research and policy work is focused on h...Read More
#APLAR22 Program: 'GRAPPA Symposium' Brought to you by UCB Session highlights...Read More
If you're looking for the perfect place to stay whilst attending #APLAR22, be su...Read More
#APLAR22 Program highlights: 'Human rights in the management of #rheumaticdisord...Read More
APLAR 2022 Plenary Speaker highlight: Prof. Thomas developed and tested antigen-...Read More
Early bird rates for #APLAR22 have been extended to 30 September. Take advanta...Read More
Sarfaraz Hasni is the Director of Lupus Clinical Research at the National Institute of Arthritis, Musculoskeletal, and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) in Bethesda, Maryland, USA. He did his post-graduate training in Internal Medicine and Rheumatology from State University of New York at Stony Brook and a master’s in clinical research from Duke University. Dr. Hasni conducted several proof-of-concept clinical trials. He is the recipient of William G. Coleman Minority Health and Health Disparities Research Innovation Award. He has served as scientific reviewer for multiple research grants and has been invited to present his research at regional and international conferences, medical grand rounds, and patient summits.
David Siew Kit Choon is a retired Professor of Orthopaedic Surgery at University Malaya Medical Centre in Kuala Lumpur. He was head of arthroplasty from 1997 until 2014. He is now in private practice. He has been the Chairman or the Hip section of the Asia Pacific Orthopaedic Association, President of the Asia Pacific CAOS (computer assisted Orthopaedic surgery) and President elect of the Asia Pacific Arthroplasty Society (APAS)
Dr Cheung is currently Head and Senior Consultant at the Division of Rheumatology, National University Hospital, Singapore. He underwent clinical and research training in Australia and France. His current research interests are in inflammatory arthritis and ultrasonography and has been actively involved in activities involving ultrasonography in rheumatology nationally over the past 10 years. In addition, he has been an integral core faculty member in the Division’s Rheumatology Senior Residency program since its inception.
Associate professor, Department of Rheumatology, PUMCH
Vice-President, Chinese Rheumatology Association (CRA), Young Rheumatologist Committee
Vice-President, Chinese Rheumatology and Immunology Physicians Association (CRIPA), Young Rheumatologist Committee
Secretary and member of the Committee, Beijing Rheumatology Association
Secretary, Chinese SLE Treatment and Research group (CSTAR) & Chinese Rheumatism Data Center (CRDC)
Secretary, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID)
2018 Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Professor and Chairman
2014 Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Associate Professor
2011 The First Department of Internal Medicine, Uni of Occupational and Environmental Health, Japan, Lecturer
2005 The First Department of Internal Medicine, Uni of Occupational and Environmental Health, Japan, Assistant Professor
2001 NIAMS/NIH Visiting Fellow
1995 Kyushu University Research Fellow
1994 First Department of Internal Medicine, Kyushu University Hospital
Director of Rheumatology and Immunology Department, Shantou Central Hospital
Won the 2018 “Outstanding Younger Medical Talents” of Guangdong Province Award
Won the 2021 “Outstanding Younger Award” of Rheumatology Branch of Guangdong Medical Association
Published 24 peer-reviewed articles on professional journal, including ARD, Rheumatology, ART, Clinical Rheumatology, Lupus etc.
Current research focuses on connective tissue disease related pulmonary diseases and mechanism of familial autoimmunity diseases in Chaoshan population.
Medical Partners Korea, Shareholder, Chief Policy Officer, Rheumatologist
Chief External Rheumatologist of the Ministry of Health of the Republic of Kazakhstan
Qazaq College of Rheumatology RPA, Chairman
Date of birth: 02.11.1974, Kazakh
Knowledge of the languages: Kazakh, Russian, English, Korean with a dictionary
Place of residence: Almaty, CC “Tabigat”, house 36a
Phone: +7 701 222 8814
Work experience: 24 years
Pioneer in Pediatric Rheumatology in Bangladesh. Currently working as Professor of Paediatrics in Bangabandhu Sheikh Mujib Medical University.
Dr. Pisitkun is an immunologist-rheumatologist committed to scrutinizing the roots of systemic lupus erythematosus (SLE) at their breadth and depth via state-of-the-art tools and imaginations. At the NIAID, she discovered TLR7 as a susceptibility gene for SLE. She has continued translating immunogenomics investigations in lupus mice and SLE patients into actionable treatment solutions in Thailand. She has developed a panel of inflammatory cytokines to use as guidance for her patients’ precision management. During the early stage of the COVID-19 pandemic, her strong public spirit led to a call out to the Thai government to act on bringing a more proper vaccination platform for the Thai population. In March 2022, she was elected president of the Thai Rheumatism Association.
Dr Pang Hin-ting Steve, is currently the Associate Consultant in the division of Rheumatology team at the Department of Medicine and Geriatrics at Kwong Wah Hospital, a regional acute hospital situated in Central Kowloon. He obtained his medical degree in the University of Hong Kong in 2005 and completed his training in rheumatology in 2013. Over the last decade, he has been active in the field of rheumatology, working as the Council Member of Hong Kong Society of Rheumatology Education & Research Foundation and Co-op member of Hong Kong Society of Rheumatology. He is currently one of the reviewers of International Journal of Rheumatic Diseases.
Professor, Konkuk University School of Medicine
Dr Lee graduated from the Chinese University of Hong Kong and obtained her Fellowship of Medicine (Rheumatology) in HK and Edinburgh. Currently she is the consultant and team head of Rheumatology Division in Pamela Youde Netheresole Eastern Hosptial. Her special interest is in musculoskeletal ultrasound and inflammatory arthritis. She had published number of papers and abstracts concerning the related topic.
Dr. LAI is a specialist in Rheumatology, currently working as the associate consultant in Tseung Kwan O Hospital, Hong Kong.
His special interest is psoriatic arthritis and its co-morbidities.
Dr Kitty Kwok is currently the council member of Hong Kong Society of Rheumatology. She is working as associate consultant in Queen Elizabeth Hospital since 2016. Her main field of interest is rheumatoid arthritis and contributes in local rheumatoid arthritis registry. Future aspiration would be to apply artificial intelligence in RA imaging.
Hideto Kameda, M.D., Ph.D. is Professor of Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Japan. (2013-present)
He received a PhD from Keio University School of Medicine, Tokyo in 1991. He was a post-doctoral fellow at National Institute of Environmental Health Sciences (NIEHS) and National Institutes of Health (NIH), USA from 1997 to 2000.
Prof. Kameda’ research interests focus on the pathogenesis of collagen disease and intractable pathology, optimizing biological therapy and evaluation of arthritis by ultrasound of joints and he has also been engaged in clinical trials and studies of novel agents in inflammatory arthritis.
Prof. Kameda is a member of multiple review boards in the Ministry of Health, Labour and Welfare, an editorial member of 4 academic journals, and a peer reviewer of more than 30 academic papers annually. Prof. Kameda has served as a director of Japan Society for Clinical Immunology and Japan Spondyloarthritis Society.
Dr Ho is a Rheumatology specialist trained up in Hong Kong. She obtained her Medical Degree in The Chinese University of Hong Kong. She had overseas training in Leiden University Medical Centre in 2012. She has been working in public hospital in Hong Kong for 20 years. She involves in patient care, research work and education.
Assunta Ho finished her training and received the Fellowship of the Hong Kong College of Paediatrician and Hong Kong Academy of Medicine in 2006. She is now the Associated Consultant at the Prince of Wales Hospital and the Honorary Clinical Associate Professor at the Chinese University of Hong Kong.
Inspired by Dr Joannie Hui, Dr Ho develops an interest in paediatric rheumatology early in her career. In 2008, she was awarded the HM Lui Fellowship to pursue training at the Great Ormond Street Hospital for Children in the United Kingdom. She is now the vice president of the Hong Kong Society for Paediatric Rheumatology and a member of the APLAR Paediatric Rheumatology Special interest Group. She has been leading several initiatives, including an updated on the local JIA treatment algorithm and the Hong Kong JIA registry.
Dr. SA Haq, Chief Consultant, Green Life Center for Rheumatic Care and Research, and former Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University (BSMMU) established the first Rheumatology Clinic of the country in October 1991. He was one of the co-founders of Bangladesh Rheumatology Society in 1997 and now is its President. In June 2000, as Chief Investigator, he founded the COPCORD Study Group in Bangladesh. The group has completed stage I COPCORD study and is carrying out stage II and III activities. He became Professor of Medicine (Rheumatology) in July 2001and Professor of Rheumatology in July 2006. He was awarded Fellowship of the Royal College of Physicians of Edinburgh in 2003 and International Fellowship of the American College of Rheumatology in 2005. Dr. Haq’s areas of academic interest include Epidemiology of rheumatic disorders, rheumatoid arthritis, spondyloarthritis and SLE. He has 157 publications in local and international journals out of which 104 are originals. He was awarded a Gold Medal by “Bangladesh Academy of Sciences” for contribution to the advancement of Science in the country. He has served Asia-Pacific League of Associations for Rheumatology (APLAR) in the capacities of APLAR-COPCORD (Community Oriented Program for Control of Rheumatic Disorders) coordinator, Vice President, Treasurer and President. Currently, Dr. Haq is holding the position of Immediate Past President in APLAR.
Prof Samina Ghaznavi, MBBS, MCPS, FCPS, FACR is a Consultant in Internal Medicine and Rheumatology. She is the current President of Pakistan Society for Rheumatology, and also member APLAR Special Interest Group for Osteoarthritis.
She graduated from Sind Medical College, (Karachi) where she was given the award of “Best Graduate of the year” with distinctions and gold medals in Medicine and Surgery.
She did her fellowship in Medicine from Jinnah Post Graduate Medical Center Karachi. Her special interest was Rheumatology
She spearhead genetic research in Pakistan in “The association of HLA DR 4 with Rheumatoid Arthritis”
She worked in, Liaqat National Hospital, Karachi in the department of Medicine, and has to her credit close to a hundered postgraduates in Medicine.
Dr Monika de Silva
Dr Monika de Silva is a consultant rheumatologist in National Hospital of Sri Lanka(NHSL) ,the premier tertiary care hospital of the country.She is also an honorary senior lecturer in the faculty of Medicine, University of Colombo.
Dr Monika is the immediate past president of College of Specialists in Rheumatology & Rehabilitation Sri Lanka.She is a member of the Specialty Board in Rheumatology & Rehabilitation, of Post Graduate Institute of Medicine(PGIM), University of Colombo. She is also a member of the specialty board in Sports & Exercise Medicine in PGIM.
She completed fellowship in Rheumatology in University of Alberta, Edmonton.
Her special interests include early treatment of rheumatoid arthritis with methotrexate and leflunomide, management of SLE with minimising steroids,vasculitis,gout and JIA.
She also has several publications in the field of rheumatology.
I am currently the council member and one of the office bearers in the Hong Kong Society of Rheumatology (HKSR). I have been the core member in the SLE special interest group (SIG) of the HKSR since 2017 and Spondyloarthritis (SpA) SIG of HKSR since 2019. Lately I also joined the APLAR SLE and SpA SIGs. I have published articles focusing on SLE and SpA in journals Rheumatology, BMC Musculoskeletal Disorders and International Journals of Rheumatic Diseases. My abstracts were accepted as posters and oral presentation by various international conferences like EULAR, ACR, and BSR. I currently serve as the Editorial Board member in Journal of Clinical Rheumatology & Immunology. I have also been invited to give various lectures to Rheumatology trainees and public regarding disease activity and damage of SLE and current treatment paradigm.
Dr Chan Kwai Yu Winnie is currently the Chief-of-Service of the Department of Paediatrics, Queen Elizabeth Hospital, Hong Kong. She graduated from the Medical School, University of Hong Kong and joined the Department of Paediatrics of Queen Elizabeth Hospital in 1990. She obtained her FHKAM and FHKCPaed in 1996 and became a Fellow of The Royal College of Paediatrics and Child Health in 2018. Dr Chan had her clinical attachment to the Paediatric Rheumatology Department in Chicago’s Ann & Robert H Lurie Children’s Hospital, a center with a leading role in the science of Juvenile Dermatomyositis and Systemic Lupus Erythematosus. To expand the scope of exposure, she had studied with Ivan Foeldvari, MD, in Germany, focusing on Juvenile Idiopathic Arthritis and scleroderma. She is currently the Chairperson of the Hong Kong Society for Paediatric Rheumatology and had lead the group in various projects in Paediatric Rheumatology.
Senior consultant and Deputy Head of the Department of Rheumatology and Clinical Immunology, University Medicine, Berlin
Frank Buttgereit is a senior consultant and deputy (and currently acting) head of the Department of Rheumatology and Clinical Immunology at the Charité, University Medicine in Berlin. He also directs a liaison research group at the Deutsche Rheuma-Forschungszentrum.
He studied Medicine at the Humboldt University Berlin, Charité, became Associate Professor/Senior Registrar in 1997, and has held the position of Professor of Rheumatology at the Charité since 2002. He has recently been appointed honorary professor for rheumatology at the Rosario University of Bogota, Colombia.
Dr. Buttgereit has expertise in the treatment of a wide variety of musculoskeletal and rheumatic diseases, including osteoporosis, osteoarthritis, rheumatoid arthritis, myositis and different forms of vasculitis. He is also internationally recognised for his work on mechanisms of glucocorticoid actions and on bioenergetics of immune functions and has been principal investigator in a variety of clinical studies on effects of anti-inflammatory agents in patients with rheumatic disease.
Dr. Buttgereit has been the recipient of research awards in 1988 (Humboldt price) and 2002 (Schuler award) and has received scholarships in 1990 (Boehringer Ingelheim Foundation), 1992-94 and 1996 (DAAD), and a BIH Clinical Fellowship (2017 – 2023). He was or is currently on the editorial board of several journals, including Ann Rheum Dis, Rheumatology, Arthritis Research & Therapy, Z Rheumatol and Inflammopharmacology, and author of more than 365 publications.
Dr. Ho SO is currently the assistant professor of the Rheumatology Unit, The Chinese University of Hong Kong. He is the honorary treasurer of the Hong Kong Society of Rheumatology.
Dr SO studied at the University of Hong Kong and attained his Medical De-gree in 2004. He became a fellow in Rheumatology in 2011. He received his Master of Science in Biostatistics and Epidemiology from the Chinese Univer-sity of Hong Kong in 2014.
Dr SO has authored more than fifty articles in peer-reviewed rheumatology journals including ARD, A&R and Rheumatology. He is the associate editor of the Journal of Clinical Rheumatology and Immunology. He is the convener of APLAR myo-sitis SIG. His main research interests are inflammatory arthropathies, myositis and SLE.
Georg Schett is professor of Internal Medicine and since 2006 head of the Department of Medicine 3 – Rheumatology and Immunology at Universitätsklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg in Germany.
Professor Schett graduated from the University of Innsbruck (Austria) in 1994. After his dissertation from medical school, he worked as scientist at the Institute of BioMedical Aging Research of the Austrian Academy of Science in Innsbruck. Two years later, he joined the Department of Medicine at the University of Vienna, where he completed his postgraduate training in Internal Medicine and subsequently in Rheumatology. In 2003 he was promoted to professor of Internal Medicine. Before accepting his position as the chair of the Department of Internal Medicine 3 in Erlangen, he worked as a scientist in the United States of America for one year.
Georg Schett’s scientific work includes a broad spectrum of clinical and immunological issues, particularly the molecular basics of immune-inflammatory diseases. Initially, he investigated the immunology of atherosclerosis and focused on antibody-mediated endothelial cell damage. His research work led to the understanding of the phenomenon of LE-cells in 2007. He was awarded the renowned START Award in 2002 and established a research group for arthritis in Vienna. In 2008, he initiated in collaboration with colleagues the priority program IMMUNOBONE in Germany, funded by the German Research Foundation (DFG). IMMUNOBONE aims to elucidate the interactions between the skeletal and the immune systems. Since 2015, Prof. Schett has led the DFG collaborative research centre 1181 “Checkpoints for Resolution of Inflammation” in Erlangen. Additionally, he is spokesperson of the project METARTHROS, funded by the Federal Ministry of Education and Research, which investigates the impact of the metabolism on arthritis. In 2019, he received funding for the ERC-Synergy grant “4D+ nanoSCOPE Advancing osteoporosis medicine by observing bone microstructure and remodelling using a four-dimensional nanoscope” of which he is spokesperson. 4D nanoSCOPE aims to develop tools and techniques to permit time-resolved imaging and characterization of bone in three spatial dimensions (both in vitro and in vivo), thereby permitting monitoring of bone remodelling and revolutionizing the understanding of bone morphology and its function.
In 2021, Prof. Schett was appointed Vice President Research of Friedrich-Alexander University Erlangen-Nürnberg and also became a Leopoldina member of the National Academy of Sciences of Germany.
Professor Schett’s scientific work has been honored with several awards, including the Carol-Nachman Prize from Wiesbaden. He has published over 840 peer-reviewed papers.
Dr. Saag is Professor of Medicine and holds the Jane Knight Lowe Endowed Chair in the Department of Medicine at the University of Alabama at Birmingham. At UAB he is also Director of the Division of Clinical Immunology and Rheumatology, Director of the Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center, and Director of the Center of Research Translation in Gout and Hyperuricemia.
Proud to have grown up in the diverse city of Evanston, Illinois, where he became an Eagle Scout and graduated third in his high school class of over 1,000 students, Dr. Saag was trained as a bioengineer at the University of Michigan, and received his MD from Northwestern University. As a medical resident at Evanston Hospital, he was recognized as Outstanding Intern of the Year and as a Chief Resident. While at the University of Iowa completing his fellowship in rheumatology, he simultaneously earned an MSc in epidemiology. At Iowa, he began his interest in and pursuit of clinical epidemiology and experimental therapeutics. Dr. Saag continued at the University of Iowa as an Assistant Professor until joining the University of Alabama at Birmingham, where he has been a practicing physician, educator, and research scientist since 1998.
Dr. Saag’s research has advanced the field of implementation science and disparities research in the areas of osteoporosis and gout. His recent work has focused on methods to implement evidence into practice using novel study designs. Using cohorts and other large databases, he has contributed to an understanding of comparative effectiveness and safety of drugs in rheumatoid arthritis, osteoporosis, and gout. He has authored more than 400 peer-reviewed manuscripts, including 3 original first-author articles in the New England Journal of Medicine on treatment of glucocorticoid-induced osteoporosis and on fracture prevention in women with osteoporosis. He has also authored more than 100 reviews, editorials, and book chapters, as well as the fi rst and second editions of the clinical handbook Diagnosis and Management of Osteoporosis. He has served on the editorial boards of Arthritis Care & Research, Annals of Internal Medicine, Archives of Internal Medicine, Bone, and other biomedical journals. As a research mentor, he has trained more than 20 postdoctoral fellows and junior faculty and has been principal investigator on several large program project grants at UAB. He directs the K and T training components for the UAB Center for Clinical and Translational Science. He served a term as a standing member on the NIH Neurologic Aging and Musculoskeletal Epidemiology (NAMES) study section and chaired the Arthritis Foundation Review Commit-tee, Clinical Outcomes and Therapeutics Study Section in the past.
Dr. Saag has been frequently recognized for his contributions to research and research training. Among the honors he has received are the UAB Max Cooper Research Award in 2005, the UAB Department of Medicine Research Award (fi rst place among professors) in 2012–2014, the 2017 UAB Dean’s Excellence Award for Mentor-ship, and the 2021 European Calcified Tissue Society Excellence in Research Award. He was elected to the Association of American Physicians in 2015. In 2013 the ACR honored him with its Excellence in Investigative Mentoring Award. He has been listed in Best Doctors annually since 1996. Through his research pursuits he has been a very frequent lecturer in all continents except Antarctica and has particularly enjoyed his collaborations and visiting professorships in Latin America. Past lectureships and plenary presentations have included visits to EULAR, PANLAR, APLAR, the European Calcified Tissue Society, the International Osteoporosis Foundation, the Australian and New Zealand Bone and Mineral Society, as well as rheumatology and metabolic bone disease societies in 30 countries.
Throughout his career, Dr. Saag has served actively in numerous medical professional and patient advocacy organizations, and has been particularly focused on developing practice guidelines and quality of care indicators. In 1998–2002 he was a member of the Institute of Medicine Committee on Identifying Effective Treatment for Gulf War Veterans’ Health Problems. In the early 2000s he served on the American Medical Association Osteoarthritis Performance Measures Physicians Workgroup, the National Center for Quality Assurance Musculoskeletal Workgroup, and the American Pain Society Low Back Pain Guidelines Committee. He was a member of the Ameri-can Society for Bone and Mineral Research Advocacy Committee in 2010–2013 and Program Co-Chair of the organization’s 2017 Meet-ing Planning Committee. He served on the National Osteoporosis Foundation Board of Trustees in 2008–2013 and was Vice-President of the organization in 2014–2016 and President in 2016–2018, during which time he also served as Co-Chair of the National Bone Health Alliance. He was a member of the American Gout Society Board of Directors in 2005–2020. In addition, he has served on the FDA Arthritis Drugs Advisory Committee and on numerous panels and work-ing groups of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, including delivering the keynote address on career journey for the NIAMS K-Trainees Forum in 2019.
A member of the American College of Rheumatology since 1992, Dr. Saag’s active involvement with the ACR began early in his career. He served on the Atypical Connective Tissue Diseases Classification Criteria Subcommittee and the Ad Hoc Committee to Revise Guidelines for Glucocorticoid-Induced Osteoporosis in 1998 and on the Professional Meetings Committee in 1998–2001. He was the senior author on 2 prior iterations of the ACR rheumatoid arthritis guidelines and he served as the American delegate to past EULAR rheumatoid arthritis guidelines. He also served as the senior author on the ACR COVID-19 treatment guidance document produced in 2020. He chaired the Summer Rheumatology Meeting Planning Committee in 2001 and was a member of the Educational Products Committee and the Academic Rheumatology Workforce Ad Hoc Committee in 2002. He served as Co-Chair of the ACR Quality Measures Subcommittee in 2007–2009, as Chair of the Committee on Quality of Care in 2009–2013, and as Chair of the Committee on Corporate Relations from 2018 to 2020. During his time on these committees he helped fashion new approaches to guideline development and advised the College on public–private partnerships during the start of the pandemic. Dr. Saag was appointed to the ACR Board of Directors in 2013 and to the ACR Finance Committee in 2016. He served as ACR Secretary in 2018–2020 and as President-Elect in 2020–2021.
Dr. Saag resides in Birmingham with his wife Leah. They have 3 daughters, Jenny (Christopher) Keshishian, Lauren (Yitzi) Peet-luk, and Stefanie Saag, who work as a certified nurse anesthetist at UAB, an epidemiologist faculty member at Vanderbilt University, and a social work student in Chicago, respectively. Dr. Saag and his wife enjoy international travel, hiking, eclectic food and wine, and in particular, spending time with their children, granddaughter Clara Keshishian, parents Jim Saag and Marlene Waller, extended family/friends throughout the country, and a large cadre of family dogs.
Annamaria Iagnocco is Professor of Rheumatology and Head of the Academic Rheumatology Centre at Turin University, Italy. She is EULAR President. She is former Head of the EULAR School of Rheumatology, former co-chair of the OMERACT Ultrasound Group, Chair of the Ultrasound Study Group of the Italian Society for Rheumatology, member of several working groups on ultrasound in RMDs and faculty teacher in the EULAR Sonography Courses. Her research interests in RMDs include education, arthritis, and imaging. She is a member of the Editorial Board of prestigious international journals and has authored more than 290 peer-reviewed publications.
Prof. Dr. Zhuoli Zhang, MD., PhD.
Director of department of Rheumatology and Clinical Immunology, Peking University First Hospital.
She ever worked in UK and Netherlands for 4 years. Her major research interests include imaging in inflammatory arthritis. She is the author of 400 scientific publications.
She is currently the vice president and secretary general of Chinese Rheumatology Association
Professor Raymond Yung is the Jeffrey B. Halter Collegiate Professor of Geriatric Medicine at the University of Michigan in the United States. His clinical and research interest is in Geriatric Rheumatology. He is currently Chief of the Division of Geriatric and Palliative Medicine, Director of the Michigan Geriatrics Center and Institute of Gerontology. He also served as Chief of the Division of Rheumatology in 2018-2020 at the University of Michigan.
Chair – Section of Rheumatology, University of Santo Tomas Faculty of Medicine and Surgery
Chair – Osteoporosis Special Interest Group, Philippine Rheumatology Association
Chair – Department of Medical Education and Research, Chinese General Hospital and Medical Center
Immediate Past President – Philippine Rheumatology Association and Osteoporosis Society of the Philippines Foundation, Inc.
Dr Guochun Wang, MD,PhD
Dr. Wang is a professor of medicine, the Director of the Rheumatology Department and the Key Laboratory of Myositis at China-Japan Friendship Hospital/Peking University Teaching Hospital. He has extensive clinical and research experience of working with idiopathic inflammatory myopathies (IIMs) patients. He is the recipient of grants from the National Natural Science Foundation of China and many other research institutions. Dr. Wang has been in charge of a wide range of research programs in IIMs including observational studies, immunological studies, genetic studies, serological studies, muscle pathological and imaging studies. Moreover, Dr. Wang is the author or corresponding author of more than 100 pubmed-indexed articles which focused on myositis. Dr. Wang has been active in international myositis and rheumatology professional societies.
Ms Kwok obtained Master of Nursing degree at the University of Hong Kong in 2004 and Graduate Certificate in Rheumatology Practice in the UK in 2009.
She is now the advanced practice nurse-in-charge of Rheumatology and Clinical Immunology Centre of Grantham Hospital. She is also the Chairman of education committee and executive member of the Hong Kong Arthritis and Rheumatism Foundation.
She was the program development committee member of the Hong Kong rheumatology nursing curriculum and core working group member of the Asia-Pacific Initiative for Rheumatology Nurse Education since 2016.
Ms Kwok was the author of randomized control trial on nurse-led consultation for patients with rheumatoid arthritis; co-author of published articles on SpA, Rheumatology Nurse education and development in Asia Pacific. She has ongoing research collaboration with EULAR champion countries on recommendations for patient education in inflammatory arthritis.
Kichul Shin is a Rheumatologist, and Professor of Seoul National University (SNU), Seoul, Korea. He completed his fellowship at SNU hospital and Brigham and Women’s Hospital in Boston, USA. He is the Chair of the Clinical & Basic Research Committee of the Korean College of Rheumatology, and has been running the biologic register, KOBIO as Director since 2013. He is also a member of the APLAR Executive Committee, and APLAR Center of Excellence Committee.
Dr. Scott is Professor and head of Paediatric Rheumatology at Red Cross War Memorial Children’s Hospital and the University of Cape Town. He is currently interim director of the Clinical Research Center at UCT. His research and educational focus is on the care of patients with rare and rheumatic diseases in Africa and other less resourced communities. Prof Scott has a special interest in access to care, Paediatric Vasculitis, SLE, Juvenile Idiopathic Arthritis and Fibrodysplasia Ossificans Progressiva. He is the PReS Chairperson of the Global Task Force for Musculoskeletal Health Task Force and chair of the International Clinical Council for FOP. He also serves on the Steering committee of the Paediatric Society of the African League of Associations for Rheumatology.
Dr Anthony Sammel is a rheumatologist in Sydney, Australia with a subspecialty interest in vasculitis. He works at Prince of Wales Hospital and is a conjoint senior lecturer at the University of New South Wales. He completed a PhD in advanced PET/CT imaging and biomarkers in giant cell arteritis and is a director of the Australian and New Zealand Vasculitis Society (ANZVASC). Dr Sammel’s research focuses on imaging in large vessel vasculitis.
Dr. Putterman serves as Associate Dean for Research in the Azrieli School of Medicine of Bar-Ilan University, and Director of the Research Institute in the Galilee Medical Center. In addition, Dr. Putterman is Professor of Medicine and Microbiology & Immunology at the Albert Einstein College of Medicine and Montefiore Medical Center (Bronx, New York).
Dr. Putterman’s major research interests are in the field of immunology and autoimmune diseases, and specifically the identification and characterization of novel mechanisms, biomarkers, and treatment approaches to immune mediated nephritis, neuropsychiatric lupus, and systemic lupus erythematosus. Dr. Putterman’s laboratory has received funding from the National Institute of Health, Alliance for Lupus Research, Lupus Research Institute, Arthritis Foundation, Boehringer Ingelheim, and Biogen Idec, and he has published more than 200 articles and book chapters in the medical and scientific literature. He was elected to the American Society of Clinical Investigation, and is a member of the American College of Rheumatology and the American Association of Immunologists. Dr. Putterman has served on multiple NIH and international study sections, and is currently a member of several editorial boards.
Dr Kade Paterson is a NHMRC Emerging Leadership Fellow and a Dame Kate Campbell Senior Research Fellow with the Centre for Health, Exercise and Sports Medicine at the University of Melbourne. He is also a Certified Sports Podiatrist with Lakeside Sports Medicine Centre. Kade’s research expertise is in conducting large clinical trials testing non-drug, non-surgical interventions for musculoskeletal conditions, and for osteoarthritis in particular. He has published more than 65 peer-reviewed articles in international journals, is a co-author of a biomechanics textbook and has presented at numerous national and international conferences. Kade’s clinical career has spanned 15 years, where he works widely with professional and recreational athletes and clubs from around Australia, including his current role with Melbourne United in the National Basketball League. He is the President of Sports and Exercise Podiatry Australia, is on the Victorian Council for Sports Medicine Australia, and is a Fellow of the Australian Sports Medicine Federation.
Kenji Oku is an associate professor of the Department of Rheumatology and Infection Diseases at the Kitasato University, Japan. His interests have focused on both basic science and clinical research in SLE and the antiphospholipid syndrome.
Most recently, as the member of the standing committee of the APLAR, he and his colleagues published the Consensus Statements on the Management of SLE. Additionally, as fellow of Japan College of Rheumatology (JCR), he holds various senior level positions in the JCR, including the executive director of the standing committee of the Japanese clinical guidelines of SLE and the senior member of the task force against COVID-19.
Dr. Ogdie is Associate Professor of Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania. She is an expert in the care of patients with PsA, Director of the Penn Psoriatic Arthritis and Spondyloarthritis Program and Deputy Director of the Penn Center for Clinical Epidemiology and Biostatistics. Her research program is focused psoriatic arthritis (PsA), an inflammatory arthritis that affects up to 30% of patients with psoriasis. The mission of her research program is to improve outcomes in PsA by accelerating diagnosis, increasing the focus on meaningful, patient-centered outcomes, and developing and advancing methods for precision medicine.
Rachel Nelligan is a registered clinical physiotherapist and research fellow in the Department of Physiotherapy at the University of Melbourne. As an early career researcher Rachel has been involved in the design, development and execution of >7 randomised controlled trials researching osteoarthritis, pelvic health and exercise with a particular focus on digital-health and behaviour change. Rachel has >21 peer-reviewed publications and recently received the 2021 Australian Rheumatology Association’s New Investigator Award and the 2021 Australian Clinical Trials Alliance’s Emerging Leader Award for her work in digitally-delivered interventions for people with knee osteoarthritis. She was also a 2021 finalist for the Victorian Government’s Premier’s Awards for Health and Medical Research.
Prof. Sandra Navarra is head of Rheumatology at University of Santo Tomas Hospital in Manila, Philippines. She is co-convenor of SLE special interest group at Asia Pacific League of Associations (APLAR), steering committee member of Lupus Academy, executive board member of Asia-Pacific Lupus Collaboration, and founding member of Asia Lupus Nephritis Network. In addition to clinical practice, teaching, and numerous health advocacies, Prof. Navarra is an experienced clinical trials investigator and has published widely in the field of lupus, spondyloarthropathy and other rheumatic diseases. She is a well-known lecturer in a broad range of topics in rheumatology and recipient of several university, national and regional awards including the Philippine College of Physicians Most Distinguished Physician award and the APLAR Master award.
Ashish J Mathew is a professor of rheumatology at the Christian Medical College, Vellore, India and an adjunct research associate at the Copenhagen Center for Arthritis Research (COPECARE), Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark. He completed his basic medical education and rheumatology training in India, followed by a PhD in ‘MRI and clinical aspects of enthesitis in spondyloarthritis, including psoriatic arthritis’ from the University of Copenhagen, Denmark and an advanced clinical research fellowship in rheumatology focussing on psoriatic arthritis from the University of Toronto. His research is focussed around psoriatic arthritis and spondyloarthritis. He has 65 publications in peer reviewed journals and has authored 6 textbook chapters. He is an active member of the GRAPPA , ASAS and OMERACT MR imaging and PsA groups.
Prof. Mandl is a chief consultant and associate professor at the Division of Rheumatology, Medical University of Vienna, Austria, a EULAR Centre of Excellence and member of the EULAR Network of Imaging Research Centers. After graduating with honors from Semmelweis University, Budapest he completed my doctorate in functional neuroscience with honors at the Nathan Kline Institute in Orangeburg, New York and at Semmelweis University, Budapest.
His research interests include the use of imaging for diagnosing, monitoring and predicting rheumatic and musculoskeletal diseases, in particular the utility of ultrasound for the monitoring of inflammation and structural changes in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. He has convened and am currently convening several EULAR and OMERACT task forces which focus on various aspects of imaging. He has published over 90 peer-reviewed publications within the field of rheumatology and musculoskeletal imaging with and H-index of 28, and published a textbook on the use of musculoskeletal ultrasound for the hand.
Vidya Limaye is a staff specialist Rheumatologist in the Department of Rheumatology at the Royal Adelaide Hospital. After completing her rheumatology training she undertook a PhD in the Vascular Biology Laboratory at the Hanson Institute studying the role of sphingosine kinase in inflammation and angiogenesis. She has since established the South Australian Myositis Database; this is a large repository of over 900 patients with myositis which has enabled the study of clinical, epidemiological and immunogenetic aspects of inflammatory myopathies. She has a particular interest in myositis-specific autoantibodies and in the increasingly recognised subgroup of patients with necrotising myopathy.
A/Prof. Ying Ying LEUNG is Associate Professor at Duke-NUS Medical School, and Senior Consultant of the department of Rheumatology & Immunology of Singapore General Hospital (SGH). She is currently the head of research in the department of Rheumatology and Immunology. Her research interests are in psoriatic arthritis and osteoarthritis, focusing in evaluation and development of measurement instrument and biomarkers.
A/Prof. Leung has been the Asian chair of the GRAPPA-OMERACT Outcome Measure working group, and serves in the education committee in the Group For Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). She led the peripheral arthritis domain working group in the GRAPPA recommendation update 2021.
Dr. Victor Lee is a consultant radiologist in CUHK Medical Centre, with subspecialty interests in interventional and musculoskeletal radiology.
After graduating from the University of Hong Kong, Dr. Lee received radiology training in Queen Mary Hospital and obtained Fellowship of the Hong Kong College of Radiologists in 2019. He has published more than 30 scientific articles in various local and international peer-reviewed journals including Radiology and Skeletal Radiology.
He is a member of MRI Special Interest Group of the Hong Kong Society of Rheumatology.
Dr. Lee graduated in The University of Hong Kong in 1990. In 1998, he established rheumatology service in Pamela Youde Nethersole Eastern Hospital.
In 2004, his unit was the first to introduce rheumatology MSK ultrasound in Hong Kong. Dr Lee actively promoted MSK USG locally and internationally; he had organized many ultrasound training workshops in Hong Kong and China. Moreover, he was invited as trainer in regional ultrasound training courses and he was an accredited ultrasound trainer under EULAR.
Dr Lee currently is the Director of the Rheumatology Centre of Hong Kong Sanatorium & Hospital. He is also the Honorary Associate Professor of both the University of Hong Kong and the Chinese University of Hong Kong.
Dr Lee has been elected as the Chairman of the Hong Kong Arthritis & Rheumatism Foundation, a charitable foundation to educate the public on rheumatic diseases and to serve patients suffering from various rheumatic diseases.
Dr Vince Lau is currently the Consultant at the Department of Radiology, Gleneagles Hospital, Hong Kong. He is also Honorary Clinical Associate Professor at University of Hong Kong and Honorary Consultant at Queen Mary Hospital.
His academic interests are Interventional Radiology and Musculoskeletal Imaging & Intervention.
Professor Chak-Sing Lau is currently Chairperson of the Department of Medicine and Chairman of the Board of the Li Ka Shing Faculty of Medicine, the University of Hong Kong. He is also Chief of Service of the Queen Mary Hospital Department of Medicine.
Professor Lau graduated MBChB from the University of Dundee in 1985. In 1992, he joined the University of Hong Kong (HKU) as Lecturer in Medicine and successfully rose through the ranks to Senior Lecturer in 1997 and Professor in 2000. He returned to his Alma Mata in 2007 to become the first Chair of Rheumatology of the College of Medicine, Dentistry and Nursing Studies. In 2010, however, he began his second tenure at HKU as Chair Professor and later (2014) Daniel CK Yu Professor in Rheumatology and Clinical Immunology.
Within HKU Medicine, Professor Lau was Assistant Dean in Information Technology and Planning (2001 – 2004), Assistant Dean in Education and Student Affairs (2005 – 2007), Director of the Bau Institute of Medical and Health Sciences Education (2010 – 2018) and Associate Dean for Teaching & Learning (2013 – 2018). In 2016, he co-led the reform of the MBBS Curriculum incorporating a one-year enrichment experience for all medical students .
Professor Lau has been a major player in rheumatology in Hong Kong and beyond. Locally, he was President of the Hong Kong Society of Rheumatology (1997 – 2001) and Chairman of the Hong Kong College of Physicians Subspecialty Board in Rheumatology, Immunology & Allergy (2001 – 2007). In 2001, he founded the Hong Kong Arthritis & Rheumatism Foundation, the first and only local charity organisation that raises funds to support the psychosocial and therapeutic needs of patients with rheumatic diseases. Regionally, Professor Lau co-founded the Asian Congress on Autoimmunity, Huaxia Congress on the Management of Rheumatic Diseases and Ten Topics in Rheumatology in Asia. Notably, he was President of the Asia Pacific League of Rheumatology Associations (APLAR) between 2006 and 2008. In addition, Professor Lau led the development of the Region’s first treatment recommendations for rheumatoid arthritis and axial spondyloarthritis. In 2011, he co-founded the multi-national, multi-centre Asia Pacific Lupus Collaboration . Beyond the Asia Pacific region, Professor Lau is a member of the Outcomes in Rheumatology, European League Against Rheumatism (EULAR) Scientific Committee and EULAR Task Force on Rheumatoid Arthritis Treatment Recommendations.
Between 2016 and 2020, Professor Lau was President of the Hong Kong Academy of Medicine, having served as Vice-President (Education and Examinations) in the previous 5 years. Professor Lau sits on numerous strategic committees and working groups of the Food and Health Bureau, Hospital Authority, Department of Health and the Medical Council of Hong Kong. In December 2020, he was appointed by the Hong Kong SAR Government as Convenor of the Advisory Panel on COVID-19 Vaccines.
Dr. Kuo-Lung Lai is a rheumatologist in Taichung Veterans General Hospital (TCVGH). He got M.D. degree at National Yang-Ming University in 2001, and currently is a Ph.D. candidate in Graduate Institute of Biomedical Electronics and Bioinformatics in National Taiwan University. He had been a member of the Board of Directors of SUMROC during 2010-2012. He has been the major supervisor of musculoskeletal ultrasound (MSUS) program in TCVGH since 2013 and carried out several MSUS studies of rheumatic diseases. His current research fields include ultrasonography in rheumatoid arthritis and psoriatic arthritis, ultrafast Doppler and medical image processing. He is a reviewer of the following academic journals: Journal of Medical Ultrasound, Ultrasound in Medicine and Biology, Formosan Journal of Rheumatology, and International Journal of Rheumatic Diseases.
Mitsumasa Kishimoto is currently serves as an associate professor at Kyorin University School of Medicine.
After completing the first training in Japan, he completed an Internal Medicine Residency program at the University of Hawaii, and a Rheumatology Fellowship program at New York University. In 2006 he took the role of Program Director of the Department of Rheumatology at the Kameda Medical Center, then from 2009 to 2019, clinical program director in St Lukes International hospital before moving on to accept his current positions in 2019.
Dr Kishimoto was certified by the American Board of Internal Medicine and Rheumatology and received an ACR Distinguished Fellow Award in 2006.
He was a Steering committee member in the ‘APLAR guidelines for management of rheumatoid arthritis and is currently SIG member in Spondyloarthritis. He also serves as a Steering committee member in JCR guidelines for management of RA, PsA, and SpA, and Epidemiological survey of SAPHO syndrome in Japan.
He is a GRAPPA and ASAS member, and Japan’s Principal Investigators for the ‘ASAS-Comospa and perSpA’ studies.
Dr Kishimoto is an author of over 110 scientific publications including NEJM and Lancet articles.
Graduated from Yokohama City University School of Medicine in 2001, and completed the doctoral program at the same university’s Graduate School of Medicine in 2006. After a fellowship in internal medicine and rheumatology, I joined the US NIH/NHGRI Dr. Kastner Lab as a visiting fellow. I am currently working at Yokohama City University Hospital as an adult rheumatologist. My interests include adult autoinflammatory diseases such as Behcet’s disease, VEXAS syndrome, and adult Still’s disease.
Dinesh Khanna, MD, MSc, is Professor of Medicine and Director, University of Michigan Scleroderma Program. He holds the Frederick G.L. Huetwell Professorship in Rheumatology. Dr. Khanna has published over 450 peer-reviewed articles and book chapters. He is the Principal Investigator on National Institutes of Health and industry-sponsored clinical studies. He is the coordinating PI on investigator-initiated and pharmacetucal sponsored clinical trials in scleroderma. His current research focus on developing, validating, and refining outcome measures in rheumatic diseases and designing controlled trials. He received the prestigious 2015 Henry Kunkel Young Investigator Award from the American College of Rheumatology.
I was born in 1966 in Tabriz. I completed my high school education at Ferdowsi High School in Tabriz. I started studying medicine at Tabriz University of Medical Sciences in 1985. I studied specialty in internal medicine at Tabriz University of Medical Sciences from 1997 to 2001 and Subspecialty in rheumatology at Tehran University of Medical Sciences from 2003 to 2005. In 2005, I employed as an Assistant Professor in Internal Medicine group at medical faculty of Tabriz University of Medical Sciences. I became a professor in 2017. My positions are Research deputy in Internal Medicine group, manager of Vasculitis Registry of Connective Tissue Disease Research Center and Head of the Connective Tissue Disease Research Center. My research field is Behcet’s disease, vasculitis and palindromic rheumatism. I have 115 articles in English indexed in Scopus.
Matthew Jiang is a rheumatologist based in Melbourne, Australia who works in public and private practice, including the Osteoarthritis Hip and Knee Service at St Vincent’s Hospital.
Rebecca is an academic rheumatologist who is passionate about patient-focused care and engaging with colleagues in primary and secondary care to provide the highest quality collaborative care for people with arthritis. A University of Otago medical graduate, she undertook rheumatology training in Melbourne and her PhD examined inflammatory mechanisms in gout. Rebecca’s clinical work focuses on the assessment and management of inflammatory arthritis and her particular clinical interests include inflammatory arthritis, gout and scleroderma. Rebecca’s academic interests include outcome measures, non-pharmacological management of musculoskeletal disease, use of information technology solutions to optimise care for people with chronic rheumatic diseases and medical education.
MRCP (UK); Specialty Certificate Examination (SCE) Rheumatology (UK); International Fellow of American College of Physicians (FACP) & Rheumatology (FACR); Fellow Royal College of Physicians (FRCP) London; GradCertPRheum (Australia).
Primarily an adult rheumatologist, she interned in pediatric rheumatology, Kansas University Medical Centre, USA through an ACP International Fellowship; and acquired the Graduate Certificate in Paediatric Rheumatology (GradCertPRheum) from the University of Western Australia.
Based in Lahore, Pakistan, she is Professor and Head of Rheumatology Department National Hospital & Medical Centre, Visiting Faculty and Chair of the Paediatric Rheumatology program at Central Park Medical College.
She is Associate Editor IJRD.
She is Focal Representative Global Paediatric MSK Task Force, and Convener APLAR Paediatric Rheumatology SIG.
She is Immediate Past President, Pakistan Society for Rheumatology Co-Founder & Co-Chairperson Arthritis Care Foundation, Lahore.
Dirk Elewaut is a Full Professor of Rheumatology and Immunology and Chair of the Department of Rheumatology and Immunology at Ghent University Hospital, Ghent, Belgium, a European Alliance of Associations for Rheumatology (EULAR) and Federation of Clinical Immunology Societies (FOCIS) centre of excellence. He received his medical degree at Ghent University in 1991 and his PhD in 1997 at the same institution. Following his postdoctoral research at the University of California San Diego and the La Jolla Institute for Allergy and Immunology, CA, USA, he joined the faculty of the Department of Rheumatology at Ghent University Hospital in 2001.
He has published more than 300 scientific publications in leading scientific journals and is Principal Investigator of the Unit of Molecular Immunology and Inflammation of the VIB Center for Inflammation Research at Ghent University. Currently, he serves as Chair of the EULAR Research Center and as a member of the editorial boards of several leading rheumatology journals. He has received several awards including the 2020 Carol Nachman Award. His research interests are centred around translational aspects of immune regulation to combat inflammatory arthritis and associated joint damage, with a special focus on the link between gut and joint disease in spondyloarthritis
Dr Thorlene Egerton is a senior lecturer with the Physiotherapy Department, and a senior research fellow with the Centre for Health, Exercise & Sports Medicine. Her current research interests are in bridging the evidence-practice gap in osteoarthritis management. She is particularly interested in novel models of care and education strategies to support effective self-management and behaviour change.
Thorlene coordinates the post-graduate masters of Clinical Rehabilitation. She teaches Health Behaviour Change, Evaluation of Rehabilitation Practice and Physical Activity & Exercise subjects as well as supervising the master students’ Research Project subject.
She has published 53 articles in peer-reviewed journals and produced a short patient education video explaining knee osteoarthritis with a novel empowerment discourse
Dr Shirley Chan is a specialist in Rheumatology with special interests in spondyloarthritis and other autoimmune rheuamtic diseases. Dr Chan obtained her Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Hong Kong (HKU). She then received her specialty training in Queen Mary Hospital. She is currenlty working as a Clinical Assistant Professor in HKU. One of her research interests covers the role of imaging in spondyloarthritis, including novel MRI sequence and the potential application of artificial intelligence in image interpretation.
Dr Chan obtained her Doctor of Medicine degree from the University of British Columbia in 2001. She was a member of the College of Family Physicians of Canada before pursuing further training in psychiatry in Hong Kong in 2006. She became a Fellow of the Hong Kong College of Psychiatrists in 2013. She has published original articles in international journals in the area of mental health and spondyloarthritis.
Dr. Tash graduated from Mahidol University, Thailand in 1991. He then pursued his specialty and subspecialty training in the US and earned his American Board of Pediatrics, Allergy and Immunology and lastly, Pediatric Rheumatology at Cornell University prior to returning back to Thailand and established the first Pediatric Rheumatology department at Siriraj Hospital and Mahidol University in January 2001. He then moved back to the US and joined Children’s Hospital of Pittsburgh where he gained his research interest in scleroderma and established the first Pediatric Scleroderma clinical and research Program in 2006. Then, he developed the Localized Scleroderma Cutaneous Assessment Tool which is the well-accepted clinical assessment measures in Localized Scleroderma and has been well-accepted as the standard assessment worldwide. In 2009, he then moved back to Singapore to established its first Pediatric rheumatology clinical program and in 2011, the Asia-Pacific Pediatric Rheumatology Education and Research Network. Over the decades, he has published the epidemiologic and outcomes of children with rheumatic diseases in Singapore and Southeast Asia. He also actively involved in pediatric rheumatic diseases translational research in trying to better understand the underlying immune-mechanisms and predict outcomes. He is currently an Associate Professor, head and senior consultant at the Rheumatology and Immunology Department at KK Women’s and Children’s Hospital and Duke-NUS Medical School.
Elizabeth Ang is Senior Consultant, Paediatric Rheumatology in the Khoo Teck Puat-National University Children’s Medical Centre, National University Hospital, Singapore and Assistant Professor of the National University of Singapore Yong Loo Lin School of Medicine. She did her clinical Paediatric Rheumatology Fellowship in Boston Children’s Hospital/Harvard School of Medicine.
In her free time, she enjoys going to various countries in South East Asia to spread her love for Paediatric Rheumatology and to try and understand (and sometimes tackle, alongside local providers) the challenges of caring for children with rheumatic diseases there. She counts it her privilege to have made many friends and learnt much in the process. The COVID pandemic has restricted much of such travel in the last few years, which makes this upcoming congress especially precious to her.
Associate Professor; Clinician scientist and Editor; Interests include Digital Health, Fibrosis in rheumatic diseases and Pain pathways in rheumatic diseases.
Member of APLAR SIG on Digital Health and Telemedicine.
2019 APLAR Research Grant recipient